October 13, 2017
Lund, Sweden, 12.00 CEST, 13 October 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform announces the appointment of Helena L Brandt as its new Head of Human Resources. Her appointment is to meet the...
Highly experienced clinical drug developer to oversee R&D functions and Companys Phase 3 development program New Haven, CT, October 12, 2017 – Trevi Therapeutics, Inc. (“Trevi” or the “Company”), a late-stage clinical development company focused on developing Nalbuphine® ER for chronic pruritus (itch), today announced that it has hired Helena Brett-Smith, M.D., as Chief Development Officer. Dr. Brett-Smith has more than...


DNA analysis of 442 Viking skeletons rewrites the story of Viking culture
16. September 2020
Hope that a brain injection could cure type 2 diabetes
7. September 2020
Maude has become the stereotypical migraine patient – but it’s not quite the true picture
31. July 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge